Ex Parte Tucker et alDownload PDFPatent Trial and Appeal BoardOct 24, 201711626043 (P.T.A.B. Oct. 24, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 11/626,043 01/23/2007 Carl Estcourt Tucker 408.00110101 9489 26813 7590 10/26/2017 MUETING, RAASCH & GEBHARDT, P.A. P.O. BOX 581336 MINNEAPOLIS, MN 55458-1336 EXAMINER LOUIS, LATOYA M ART UNIT PAPER NUMBER 3771 NOTIFICATION DATE DELIVERY MODE 10/26/2017 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): ptodocketing @ mrgs .com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte CARL ESTCOURT TUCKER, TROY A. BAKER, GRAHAM PETER WILSON, PATRICK GERRARD LINNANE, IAN STEWART TABRON, WAYNE LEE BONNEFIN, STEFAN LOOK, and THOMAS BERGENS Appeal 2016-001330 Application 11/626,043 Technology Center 3700 Before THOMAS F. SMEGAL, JEFFREY A. STEPHENS, and BRENT M. DOUGAL, Administrative Patent Judges. SMEGAL, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Carl Estcourt Tucker et al. (Appellants)1 seek our review under 35 U.S.C. § 134 of the Examiner’s rejections2 under 35 U.S.C. § 103(a) of claims 1, 2, 4—11, 14—18, and 22—26 as unpatentable over Biondo (US 2006/0258964 Al, pub. Nov. 16, 2006) and Rousso (US 2008/0039752 Al, pub. Feb. 14, 2008); of claim 12 as unpatentable over Biondo, Rousso, and 1 According to Appellants, the real party in interest is Swelling Solutions, Inc. Appeal Br. 2. 2 Appeal is taken from the adverse decision of the Examiner as set forth in the Final Office Action, dated October 20, 2014 (“Final Act.”). Appeal 2016-001330 Application 11/626,043 Davidson (US 6,041,243, iss. Mar. 21, 2000)3; and of claims 19-21, 27, and 28 as unpatentable over Biondo, Rousso, and Carkner (US 2008/0188782 Al, pub. Aug. 7, 2008).4 We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. CLAIMED SUBJECT MATTER Claims 1, 2, and 19 are independent. Claim 1, reproduced below, illustrates the claimed subject matter, with disputed limitations emphasized. 1. A control unit for a medical device, wherein the medical device comprises a compression device for a limb, wherein the compression device comprises a sleeve with one or more inflatable cells, wherein the compression device comprises a fluid transfer connector fixedly positioned on the sleeve of the compression device, the control unit configured to be received at a position on the sleeve of the compression device comprising: a pump, a conduit, and control apparatus to control the flow of fluid from the pump through the conduit, wherein the conduit comprises a rigid internal passage located within the control unit which terminates in a connector configured to engage the fluid transfer connector fixedly positioned on the sleeve of the compression device as the control unit is being received on the sleeve of the compression device. 3 We correct the inadvertent inclusion of claim 14 in this rejection as it is already rejected over Biondo and Rousso. 4 Claims 3 and 13 have been canceled. Final Act. 2 2 Appeal 2016-001330 Application 11/626,043 ANALYSIS Obviousness of Claims 1, 2, 4—11, 14—18, and 22—26 over Biondo and Rousso; of Claim 12 over Biondo, Rousso, and Davidson; and of Claims 19— 21, 27, and 28 over Biondo, Rousso, and Carkner5 Claims 1, 4—11, and 22—28 We select claim 1 as the representative claim for this group, and the remaining claims in this group stand or fall with claim 1. See 37 C.F.R. § 41.37(c)(l)(iv). Regarding claim 1, the Examiner relies on Biondo for teaching a control unit for a medical device having a compression sleeve and a fluid transfer connector “fixedly positioned on the sleeve (52) of the compression device (36).” Final Act. 3 (citing Biondo, Fig. 1). More specifically, the Examiner reasons that in Biondo, [cjonduit 54 (the combination of the tubes 58 and coupler 60) can be interpreted as a fluid transfer connector because it transfers fluid and connects to the control unit .... Therefore the fluid transfer connector 54 is fixedly positioned on the sleeve via its fixedly attached tubes 58. Ans. 13 (citing Biondo, 140,11. 1—20; 1 52,11. 1—14). Appellants do not dispute that Biondo discloses a medical device having a compression sleeve (1052) and a control unit (1034) with a conduit (1038) that terminates in a coupler (1012). See Appeal Br. 12 (citing Biondo, Fig. 11). However, Appellants reason that the compressive sleeve of Biondo “includes a flexible and movable conduit (e.g., 54, 1054) having a proximal end extending into the compression sleeve (e.g., 52, 1052) and a 5 Appellants argue claims 1, 2, 4—12, and 14—28 as if all the claims were rejected as obvious over Biondo and Rousso, alone. See Appeal Br. 9-20; Reply Br. 2—7. 3 Appeal 2016-001330 Application 11/626,043 distal end terminating in a distal end coupler (e.g., 60, 1016). . . . that is configured to engage coupler (e.g., 1012) as shown, e.g., in Figure 11.” Id. From the foregoing, Appellants contend that the distal end coupler of Biondo “is not fixedly positioned on the compression sleeve (e.g., 52, 1052),” as it “is movable to any position as allowed by the length of the flexible and movable conduit (e.g., 54, 1054).” Id. More specifically, Appellants argue that as shown and described in the pending application, it is the fluid transfer connector (e.g., fluid transfer connector 18) that is fixedly positioned on the sleeve (e.g., sleeve 2) of the compression device and which itself engages the connector of the control unit (e.g., a connector 16 of the control unit); and not a proximal end of some flexible and movable tubing or conduit terminating in a distal end coupler as described in Biondo. Reply Br. 5. Appellants’ contention is unavailing as it is not commensurate with the scope of these claims, none of which is limited to “a fluid transfer connector with the distal end fixedly positioned on the sleeve of a compression device.” See Appeal Br. 22, 24, and 25, Claims App. Further, Appellants’ appear to be impliedly arguing that the claim requires the entire fluid transfer connector to be fixedly positioned on the sleeve of a compression device, however the claim is not so limited. As we are instructed by our reviewing court, “limitations are not to be read into the claims from the [Specification.” In re Van Geuns, 988 F.2d 1181, 1184 (Fed. Cir. 1993) {citing In re Zletz, 893 F.2d 319, 321 (Fed. Cir. 1989)); see also In re Self, 671 F.2d 1344, 1348 (CCPA 1982). Rather, we agree with the Examiner that Biondo’s fluid transfer connector is “fixedly positioned on 4 Appeal 2016-001330 Application 11/626,043 the sleeve of the compression device,” as recited in claim 1, because Biondo shows tubes 58 are connected to sleeve 52. See Biondo Fig. 1. For the forgoing reason, we discern no error in the Examiner’s findings and sustain the Examiner’s rejections of claims 1, 4—11, and 22—28. Claims 2, 12, and 14—21 Appellants dispute the rejections of independent claims 2 and 19, and dependent claims 12, 14—18, 20, and 21, alleging that each of the claims “describes a control unit that includes a connector (e.g., connector 16 that terminates a rigid internal passage of conduit in the control unit 10) for connection to a fluid transfer connector (e.g., fluid transfer connector 18) fixedly positioned on the sleeve of a compression device. ” Appeal Br. 10. (emphasis added). However, Appellants’ contention is unavailing as it is not commensurate with the scope of these claims, none of which is limited to “a fluid transfer connector fixedly positioned on the sleeve of the compression device.”6 See Appeal Br. 22, 24, and 25, Claims App. As we are instructed by our reviewing court, “limitations are not to be read into the claims from the [Specification.” Van Geuns, 988 F.2d at 1184. For the foregoing reasons, we discern no error in the Examiner’s findings and sustain the Examiner’s rejections of claims 2, 12, and 14—21. DECISION We AFFIRM the Examiner’s rejections of claims 1, 2, 4—12, and 14— 28. 6 Throughout the Appeal Brief and Reply Brief, Appellants incorrectly argue as if independent claims 2 and 19 recite this limitation, which they do not. 5 Appeal 2016-001330 Application 11/626,043 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(l)(iv). AFFIRMED 6 Copy with citationCopy as parenthetical citation